CIK 0001603454
- Non-accelerated filer
- Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | Dalvey David Director | Grant or award | +1,530 | 1,530 | ||
| 2026-05-04 | Dalvey David Director | Sale 10b5-1 | −25,000 | $140.68 | $3.5M | 65,000 |
| 2026-01-27 | Dalvey David Director | Sale 10b5-1 | −20,000 | $120.03 | $2.4M | 90,000 |
| 2025-11-21 | Dalvey David Director | Sale 10b5-1 | −15,000 | $100.00 | $1.5M | 110,000 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −3,137 | $44.36 | $139K | 6,188 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −4,163 | $45.24 | $188K | 2,025 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −2,025 | $46.05 | $93K | 0 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −57,044 | $43.30 | $2.5M | 167,956 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −22,377 | $44.36 | $993K | 145,579 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −16,438 | $45.29 | $744K | 129,141 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −4,141 | $46.05 | $191K | 125,000 |
| 2025-05-19 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +14,048 | 14,048 | ||
| 2024-06-04 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +8,153 | 8,153 | ||
| 2023-12-15 | Dalvey David Director | Sale | −2,940 | $14.57 | $43K | 225,000 |
| 2023-12-14 | Dalvey David Director | Sale | −5,000 | $14.75 | $74K | 227,940 |
| 2023-12-13 | Dalvey David Director | Sale | −5,000 | $14.50 | $73K | 232,940 |
| 2023-12-12 | Dalvey David Director | Sale | −2,060 | $14.61 | $30K | 237,940 |
| 2023-12-08 | Dalvey David Director | Sale | −5,000 | $15.00 | $75K | 240,000 |
| 2023-12-07 | Dalvey David Director | Sale | −5,000 | $14.85 | $74K | 245,000 |
| 2023-05-15 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +11,645 | 11,645 |
Page 1 of 2 · 36 trades